{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T05:07:39Z","timestamp":1784696859593,"version":"3.55.0"},"reference-count":56,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Sarcopenia is recognized as a significant comorbidity in patients with Cardiovascular-Kidney-Metabolic (CKM) Syndrome, yet validated prediction models for this population remain lacking. This study aimed to develop and validate a nomogram for predicting sarcopenia risk in Chinese patients with CKM syndrome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data were derived from the China Health and Retirement Longitudinal Study (CHARLS) and an independent hospital dataset. The CHARLS 2015 dataset was split into a training set and an internal validation set; the CHARLS 2011 dataset served as the external validation set; and inpatients from Guangdong Provincial Hospital of Chinese Medicine constituted the hospital validation set. Sarcopenia was diagnosed according to the 2025 Asian Working Group for Sarcopenia criteria. Least absolute shrinkage and selection operator (LASSO) regression combined with multivariable logistic regression was used for predictor selection and model development. Model performance was evaluated by discrimination, calibration, and decision curve analysis (DCA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Nine predictors were identified: age, smoking status, high-density lipoprotein cholesterol, triglycerides, uric acid, C-reactive protein, hemoglobin, chronic obstructive pulmonary disease, and chronic liver disease. The model achieved area under the curve values of 0.817, 0.808, 0.800, and 0.834 in the training, internal validation, external validation, and hospital validation sets, respectively. Calibration was satisfactory in development cohorts (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;gt;\u202f0.05), with some calibration drift in external populations. DCA confirmed clinical utility across all datasets.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The developed nomogram incorporating nine accessible predictors demonstrated robust discrimination and clinical applicability for sarcopenia risk assessment in Chinese CKM patients, supporting its use in early screening and individualized intervention.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2026.1887503","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T04:49:05Z","timestamp":1784695745000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and validation of a nomogram for identifying prevalent sarcopenia in Chinese patients with Cardiovascular-Kidney-Metabolic Syndrome"],"prefix":"10.3389","volume":"14","author":[{"given":"Chengjun","family":"Yang","sequence":"first","affiliation":[{"name":"The Second Clinical Medical College, Guangzhou University of Chinese Medicine","place":["Guangzhou, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaohui","family":"He","sequence":"additional","affiliation":[{"name":"The Second Clinical Medical College, Guangzhou University of Chinese Medicine","place":["Guangzhou, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiwen","family":"Liang","sequence":"additional","affiliation":[{"name":"The Second Clinical Medical College, Guangzhou University of Chinese Medicine","place":["Guangzhou, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junru","family":"Song","sequence":"additional","affiliation":[{"name":"The Second Clinical Medical College, Guangzhou University of Chinese Medicine","place":["Guangzhou, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zehuai","family":"Wen","sequence":"additional","affiliation":[{"name":"Center for Clinical Research, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine","place":["Guangzhou, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingying","family":"Qiu","sequence":"additional","affiliation":[{"name":"The Second Clinical Medical College, Guangzhou University of Chinese Medicine","place":["Guangzhou, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiankun","family":"Chen","sequence":"additional","affiliation":[{"name":"Center for Clinical Research, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine","place":["Guangzhou, Guangdong, China"]},{"name":"Guangdong Provincial Key Laboratory of Chinese Medicine for Prevention and Treatment of Refractory Chronic Diseases, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huayang","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Scientific Research, Guangdong Provincial Hospital of Chinese Medicine","place":["Guangzhou, Guangdong, China"]},{"name":"Guangdong Provincial Key Laboratory of Research on Emergency in TCM, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","article-title":"Cardiovascular-kidney-metabolic health: a presidential advisory from the American heart association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1681\/ASN.0000000658","article-title":"Global burden of the key components of cardiovascular-kidney-metabolic syndrome","volume":"36","author":"Xie","year":"2025","journal-title":"J Am Soc Nephrol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1001\/jama.2024.6892","article-title":"Prevalence of cardiovascular-kidney-metabolic syndrome stages in US adults, 2011\u20132020","volume":"331","author":"Aggarwal","year":"2024","journal-title":"JAMA"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.jacasi.2025.04.007","article-title":"Prevalence and mortality of cardiovascular-kidney-metabolic syndrome in China","volume":"5","author":"Zheng","year":"2025","journal-title":"JACC Asia"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1186\/s13098-025-01943-x","article-title":"Sarcopenia (defined by low muscle mass) as a predictor of disease progression and mortality in cardiovascular-kidney-metabolic syndrome","volume":"17","author":"Zooravar","year":"2025","journal-title":"Diabetol Metab Syndr"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1159\/000550891","article-title":"The relationship between sarcopenia and all-cause and cardiovascular mortality risk among middle-aged and older adults across stages 0-3 of cardiovascular-kidney-metabolic syndrome: evidence from NHANES and CHARLS","volume":"16","author":"Chen","year":"2026","journal-title":"Cardiorenal Med"},{"key":"ref7","first-page":"e078378","article-title":"TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods","volume-title":"BMJ","author":"Collins","year":"2024"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/ije\/dys203","article-title":"Cohort profile: the China health and retirement longitudinal study (CHARLS)","volume":"43","author":"Zhao","year":"2014","journal-title":"Int J Epidemiol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1038\/s43587-025-01004-y","article-title":"A focus shift from sarcopenia to muscle health in the Asian working group for sarcopenia 2025 consensus update","volume":"5","author":"Chen","year":"2025","journal-title":"Nat Aging"},{"key":"ref10","first-page":"551","article-title":"Anthropometric equation for estimation of appendicular skeletal muscle mass in Chinese adults","volume":"20","author":"Wen","year":"2011","journal-title":"Asia Pac J Clin Nutr"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s13098-024-01467-w","article-title":"Construction and evaluation of sarcopenia risk prediction model for patients with diabetes: a study based on the China health and retirement longitudinal study (CHARLS)","volume":"16","author":"Zou","year":"2024","journal-title":"Diabetol Metab Syndr"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"4139","DOI":"10.1021\/acs.jproteome.4c00522","article-title":"Plasma olink proteomics reveals novel biomarkers for prediction and diagnosis in dilated cardiomyopathy with heart failure","volume":"23","author":"Xu","year":"2024","journal-title":"J Proteome Res"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"107587","DOI":"10.1016\/j.isci.2023.107587","article-title":"Atherosclerotic plaque vulnerability quantification system for clinical and biological interpretability","volume":"26","author":"Zhang","year":"2023","journal-title":"iScience"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"155533","DOI":"10.1016\/j.metabol.2023.155533","article-title":"Epidemiology of sarcopenia: prevalence, risk factors, and consequences","volume":"144","author":"Yuan","year":"2023","journal-title":"Metab Clin Exp"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"150","DOI":"10.11005\/jbm.2024.31.2.150","article-title":"Recent update on the prevalence of sarcopenia in koreans: findings from the Korea national health and nutrition examination survey","volume":"31","author":"Kim","year":"2024","journal-title":"J Bone Metab"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1415398","DOI":"10.3389\/fpubh.2024.1415398","article-title":"The prevalence of sarcopenia and risk factors in the older adult in China: a systematic review and meta-analysis","volume":"12","author":"Meng","year":"2024","journal-title":"Front Public Health"},{"key":"ref17","first-page":"109","article-title":"The mediating role of inflammaging between mitochondrial dysfunction and sarcopenia in aging: a review","volume":"12","author":"Xu","year":"2023","journal-title":"Am J Clin Exp Immunol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"4300","DOI":"10.3390\/ijms25084300","article-title":"Emerging therapeutic strategies in sarcopenia: an updated review on pathogenesis and treatment advances","volume":"25","author":"Najm","year":"2024","journal-title":"Int J Mol Sci"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1186\/s12877-024-04993-4","article-title":"Effects of cigarette smoking associated with sarcopenia in persons 60 years and older: a cross-sectional study in Zhejiang province","volume":"24","author":"Lin","year":"2024","journal-title":"BMC Geriatr"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"E843","DOI":"10.1152\/ajpendo.00301.2007","article-title":"Smoking impairs muscle protein synthesis and increases the expression of myostatin and MAFbx in muscle","volume":"293","author":"Petersen","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1164\/rccm.201410-1830PP","article-title":"Smoking-induced skeletal muscle dysfunction: from evidence to mechanisms","volume":"191","author":"Degens","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1016\/j.clnu.2024.08.017","article-title":"High-density lipoprotein cholesterol level and risk of muscle strength decline and sarcopenia in older adults","volume":"43","author":"Hua","year":"2024","journal-title":"Clin Nutr"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s12877-024-04761-4","article-title":"Dyslipidemia is associated with sarcopenia of the elderly: a meta-analysis","volume":"24","author":"Bi","year":"2024","journal-title":"BMC Geriatr"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"112560","DOI":"10.1016\/j.exger.2024.112560","article-title":"The relationship between serum lipid with sarcopenia: results from the NHANES 2011\u20132018 and bidirectional mendelian randomization study","volume":"196","author":"Huang","year":"2024","journal-title":"Exp Gerontol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3390\/jcm15010183","article-title":"Association between high-density lipoprotein cholesterol levels and sarcopenia in elderly Koreans","volume":"15","author":"Huh","year":"2025","journal-title":"J Clin Med"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1161\/ATVBAHA.108.181438","article-title":"Interrelationships among HDL metabolism, aging, and atherosclerosis","volume":"29","author":"Walter","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"e70000","DOI":"10.1002\/jcsm.70000","article-title":"Impact of adipose tissue and lipids on skeletal muscle in sarcopenia","volume":"16","author":"Jang","year":"2025","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3390\/geriatrics10030076","article-title":"Relationship between metabolic syndrome indicators within reference ranges and sarcopenia in older women-a 4-year longitudinal study","volume":"10","author":"Iida","year":"2025","journal-title":"Geriatrics (Basel)"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"5086","DOI":"10.1038\/s41598-026-35907-6","article-title":"The triglyceride HDL cholesterol ratio predicts sarcopenia risk in an aging national cohort from China","volume":"16","author":"Ye","year":"2026","journal-title":"Sci Rep"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"499","DOI":"10.2147\/CIA.S67872","article-title":"Association between muscle mass and adipo-metabolic profile: a cross-sectional study in older subjects","volume":"10","author":"Perna","year":"2015","journal-title":"Clin Interv Aging"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"17538","DOI":"10.1038\/s41598-023-44704-4","article-title":"The association of lipid metabolism and sarcopenia among older patients: a cross-sectional study","volume":"13","author":"Jiang","year":"2023","journal-title":"Sci Rep"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/art.42301","article-title":"Associations between low serum urate, body composition, and mortality","volume":"75","author":"Baker","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"3097","DOI":"10.3390\/nu15143097","article-title":"Longitudinal association between uric acid and incident sarcopenia","volume":"15","author":"Zhou","year":"2023","journal-title":"Nutrients"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.mad.2008.04.008","article-title":"Higher circulating levels of uric acid are prospectively associated with better muscle function in older persons","volume":"129","author":"Macchi","year":"2008","journal-title":"Mech Ageing Dev"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"2961","DOI":"10.1007\/s00198-013-2377-7","article-title":"Higher serum uric acid is associated with higher bone mass, lower bone turnover, and lower prevalence of vertebral fracture in healthy postmenopausal women","volume":"24","author":"Ahn","year":"2013","journal-title":"Osteoporos Int"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"101185","DOI":"10.1016\/j.arr.2020.101185","article-title":"Markers of inflammation and their association with muscle strength and mass: a systematic review and meta-analysis","volume":"64","author":"Tuttle","year":"2020","journal-title":"Ageing Res Rev"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"3362336","DOI":"10.1155\/2024\/3362336","article-title":"C-reactive protein level as a novel serum biomarker in sarcopenia","volume":"2024","author":"Lin","year":"2024","journal-title":"Mediat Inflamm"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1249\/MSS.0000000000000975","article-title":"Disease-induced skeletal muscle atrophy and fatigue","volume":"48","author":"Powers","year":"2016","journal-title":"Med Sci Sports Exerc"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1424227","DOI":"10.3389\/fmed.2024.1424227","article-title":"Association between sarcopenia and hemoglobin level: a systematic review and meta-analysis","volume":"11","author":"Wang","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1081843","DOI":"10.3389\/fpubh.2023.1081843","article-title":"Hemoglobin level is negatively associated with sarcopenia and its components in Chinese aged 60 and above","volume":"11","author":"Liu","year":"2023","journal-title":"Front Public Health"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1515\/raon-2015-0046","article-title":"Red blood cell transfusion and skeletal muscle tissue oxygenation in anaemic haematologic outpatients","volume":"50","author":"Podbregar","year":"2016","journal-title":"Radiol Oncol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nutres.2017.01.001","article-title":"Protein and exercise in the prevention of sarcopenia and aging","volume":"40","author":"Naseeb","year":"2017","journal-title":"Nutr Res"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.cca.2020.12.005","article-title":"Mitochondrial iron metabolism and its role in diseases","volume":"513","author":"Gao","year":"2021","journal-title":"Clin Chim Acta"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"e0300730","DOI":"10.1371\/journal.pone.0300730","article-title":"Chronic obstructive pulmonary disease as a risk factor for sarcopenia: a systematic review and meta-analysis","volume":"19","author":"Yu","year":"2024","journal-title":"PLoS One"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"850964","DOI":"10.3389\/fphys.2022.850964","article-title":"Pathogenesis of sarcopenia in chronic obstructive pulmonary disease","volume":"13","author":"Ma","year":"2022","journal-title":"Front Physiol"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1007\/s00109-008-0373-8","article-title":"Nuclear factor-kappa B signaling in skeletal muscle atrophy","volume":"86","author":"Li","year":"2008","journal-title":"J Mol Med (Berl)"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"669","DOI":"10.2147\/COPD.S130790","article-title":"Sarcopenia correlates with systemic inflammation in COPD","volume":"12","author":"Byun","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1378\/chest.124.1.83","article-title":"Catabolic\/anabolic balance and muscle wasting in patients with COPD","volume":"124","author":"Debigar\u00e9","year":"2003","journal-title":"Chest"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"637.e1","DOI":"10.1016\/j.jamda.2017.04.016","article-title":"Increased myogenic and protein turnover signaling in skeletal muscle of chronic obstructive pulmonary disease patients with sarcopenia","volume":"18","author":"Kneppers","year":"2017","journal-title":"J Am Med Dir Assoc"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1342100","DOI":"10.3389\/fnut.2023.1342100","article-title":"Correlation between sarcopenia and cirrhosis: a meta-analysis","volume":"10","author":"Cui","year":"2023","journal-title":"Front Nutr"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.1002\/jcsm.13334","article-title":"Impact of sarcopenia on the survival of patients undergoing liver transplantation for decompensated liver cirrhosis","volume":"14","author":"Zhou","year":"2023","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1002\/jpen.2508","article-title":"Association between skeletal muscle index prior to liver transplantation and 1-year mortality posttransplant","volume":"47","author":"Bot","year":"2023","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"112571","DOI":"10.1016\/j.exger.2024.112571","article-title":"Sarcopenia in cirrhosis: from pathophysiology to interventional therapy","volume":"196","author":"Chen","year":"2024","journal-title":"Exp Gerontol"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"392","DOI":"10.20524\/aog.2023.0804","article-title":"Mechanisms of sarcopenia in liver cirrhosis and the role of myokines","volume":"36","author":"Geladari","year":"2023","journal-title":"Ann Gastroenterol"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.ecl.2023.02.004","article-title":"Metabolic-associated fatty liver disease and sarcopenia","volume":"52","author":"Bali","year":"2023","journal-title":"Endocrinol Metab Clin N Am"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"glag160","DOI":"10.1093\/gerona\/glag160","article-title":"An appropriate ASMI cutoff value enhances utilization of the CHARLS database for studying sarcopenia","volume":"81","author":"An","year":"2026","journal-title":"J Gerontol A Biol Sci Med Sci"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1887503\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T04:49:08Z","timestamp":1784695748000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1887503\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":56,"alternative-id":["10.3389\/fpubh.2026.1887503"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2026.1887503","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"article-number":"1887503"}}